We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be applied across a vast array of indications to create victories for patients most in need.
Industry
Biotechnology Research, Scientific Research and Development Services, Services
HQ Location
4000 Shoreline Ct
Suite 300
South San Francisco, California 94080, US
Keywords
BiotechnologyAutoimmune DiseaseImmunologyOncologyDrug DiscoveryDrug Developmentprotein secretion inhibitorcompute netinhibition protein secretiondevelopment and therapeutic